We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
The Tycoon Herald
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Reading: EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com
Sign In
The Tycoon HeraldThe Tycoon Herald
Font ResizerAa
Search
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© Tycoon Herald. All Rights Reserved.
EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com
The Tycoon Herald > Business > EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com
Business

EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com

Tycoon Herald
By Tycoon Herald 4 Min Read
Share
SHARE

EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com

WATERTOWN, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) — EyePoint Prescribed drugs, Inc. (NASDAQ: NASDAQ:), an organization dedicated to growing and commercializing therapeutics to assist enhance the lives of sufferers with severe retinal illnesses, right this moment introduced that the Firm granted non-statutory inventory choices to new workers as inducement awards outdoors the Firm’s 2023 Lengthy-Time period Incentive Plan in accordance with NASDAQ Itemizing Rule 5635(c)(4).

The Firm granted inventory choices to buy as much as an combination of 54,600 shares of EyePoint Prescribed drugs frequent inventory to 6 new workers. The inventory choices had been granted on December 13, 2024. The grants had been accredited by the Compensation Committee and made as an inducement materials to every worker coming into into employment with EyePoint Prescribed drugs in accordance with NASDAQ Itemizing Rule 5635(c)(4). The choice awards have an train value of $7.46 per share, the closing value of EyePoint Prescribed drugs’ frequent inventory on December 13, 2024. The choices have a ten-year time period and vest over 4 years, with 25% of the unique variety of shares vesting on the primary anniversary of the relevant worker’s date of grant and the rest vesting in equal month-to-month installments over the next three years. Vesting of the choices is topic to the worker’s continued service with EyePoint Prescribed drugs via the relevant vesting dates.

About EyePoint Prescribed drugs

EyePoint Prescribed drugs (Nasdaq: EYPT) is a clinical-stage biopharmaceutical firm dedicated to growing and commercializing progressive therapeutics to assist enhance the lives of sufferers with severe retinal illnesses. The Firm’s pipeline leverages its proprietary bioerodible Durasert E™ expertise for sustained intraocular drug supply. The Firm’s lead product candidate, DURAVYU™ (f/ok/a EYP-1901), is an investigational sustained supply remedy for VEGF-mediated retinal illnesses combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with bioerodible Durasert E™. DURAVYU is presently in Section 3 international, pivotal scientific trials as a sustained supply remedy for moist AMD (NASDAQ:), the main explanation for imaginative and prescient loss amongst individuals 50 years of age and older in the US, and in a Section 2 scientific trial in DME. EyePoint expects full topline knowledge from the Section 2 scientific trial in DME in Q1 2025 and topline knowledge from each Section 3 pivotal trials in moist AMD in 2026.

Pipeline packages embrace EYP-2301, a TIE-2 agonist, razuprotafib, formulated in Durasert E™ to probably enhance outcomes in severe retinal illnesses. The confirmed Durasert ® drug supply expertise has been safely administered to 1000’s of affected person eyes throughout 4 U.S. FDA accredited merchandise. EyePoint Prescribed drugs is headquartered in Watertown, Massachusetts.

Vorolanib is licensed to EyePoint completely by Equinox Sciences, a Betta Prescribed drugs affiliate, for the localized remedy of all ophthalmic illnesses outdoors of China, Macao, Hong Kong and Taiwan.

DURAVYU™ has been conditionally accepted by the FDA because the proprietary identify for EYP-1901. DURAVYU is an investigational product; it has not been accredited by the FDA. FDA approval and the timeline for potential approval is unsure.

For EyePoint Prescribed drugs:

Buyers:
Christina Tartaglia
Precision AQ (previously Stern (AS:) IR)
Direct: 212-698-8700
[email protected]

Media Contact:
Amy Phillips
Inexperienced Room Communications
Direct: 412-327-9499
[email protected]

Supply: EyePoint Prescribed drugs, Inc.

You Might Also Like

Joseph Safina’s Driven Becomes Amazon Bestseller, Blending High Finance with High Speeds

Fashion Designer Hyeonseo Irene Park: Redefining Menswear Through Originality and Collaboration

From Pattaya to the World: Bryan Flowers’ Unstoppable Rise as a Global Entrepreneur

Astana International Forum 2025: “Connecting Minds, Shaping the Future”

Investment success: GP Fatih Marketing Research Co LLC and the gold dream in Africa

TAGGED:5635c4EyePointGrantsInducementInvesting.comListingNasdaqPharmaceuticalsReportsrule
Share This Article
Facebook Twitter Email Copy Link Print
Holding your nerve in Donald Trump’s tariff maelstrom
Economy

Holding your nerve in Donald Trump’s tariff maelstrom

This text is an on-site model of our Commerce Secrets and techniques publication. Premium subscribers can join right here to get the publication delivered each Monday. Commonplace subscribers can improve…

By Tycoon Herald 12 Min Read
How I Made My Morning Routine Stick (With out Hating Myself) | FashionBeans
July 7, 2025
VIDEO: Doorcam Captures Taking pictures Meteor Exploding Into Enormous Fireball Over Colorado
July 7, 2025
Katy Perry Stuns in Black Bikini, Hanging Out With Buddies on Yacht After Breakup
July 7, 2025
England suffered towards bodily France in Euro 2025 defeat – Sarina Wiegman should appropriate points earlier than going through Netherlands
July 7, 2025

You Might Also Like

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters
Business

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters

By Tycoon Herald 6 Min Read
Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com
Business

Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com

By Tycoon Herald 5 Min Read
EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com
Business

EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com

By Tycoon Herald 4 Min Read

More Popular from Tycoon Herald

MEET THE FATHER OF COADUNATE ECONOMIC MODEL
BusinessTrending

MEET THE FATHER OF COADUNATE ECONOMIC MODEL

By Tycoon Herald 2 Min Read
Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

By Tycoon Herald
Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments
InnovationTrending

Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments

By Tycoon Herald 7 Min Read
BusinessEntertainment

BTS Singer V Could Be The First Korean Artist To Hit No. 1 On One Billboard Chart

V for BTS 5th anniversary party in LA photoshoot by Dispatch, May 2018 (Credit Dispatch Creative…

By Tycoon Herald
Fashion

12 Greatest Pocket Squares – Elevate Your Formal Put on 2024 | FashionBeans

We independently consider all beneficial merchandise and sercives. Any services or products put ahead seem in…

By Tycoon Herald
Trending

U.S. Blew Up a C.I.A. Post Used to Evacuate At-Risk Afghans

A controlled detonation by American forces that was heard throughout Kabul has destroyed Eagle Base, the…

By Tycoon Herald
Leadership

Northern Lights: 17 Best Places To See Them In 2021

Who doesn’t dream of seeing the northern lights? According to a new survey conducted by Hilton, 59% of Americans…

By Tycoon Herald
Real Estate

Exploring Bigfork, Montana: A Little Town On A Big Pond

Bigfork, Montana, offers picturesque paradise in the northern wilderness. National Parks Realty With the melting of…

By Tycoon Herald
Leadership

Leaders Need To Know Character Could Be Vital For Corporate Culture

Disney's unique culture encourages young employees to turn up for work with smiles on their faces.…

By Tycoon Herald
The Tycoon Herald

Tycoon Herald: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 news.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Terms of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© Tycoon Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?